K-numberK243303
Device nameZiehm Vision RFD 3D
ApplicantZiehm Imaging GmbH
Product codeOWB
Device classClass II
Decision dateJan 21, 2025
DecisionSubstantially Equivalent
Regulation892.1650
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Ziehm Vision RFD 3D is a mobile fluoroscopic X-ray imaging system that provides 2D and 3D pulsed and continuous imaging for adult and pediatric patients. It assists physicians in visualizing anatomical structures during interventional, surgical, and diagnostic procedures across multiple specialties including cardiology, orthopedics, neurosurgery, and maxillofacial surgery.

Technological characteristics

The key modification is a software update to version 7.10.0 incorporating the 2k imaging chain 'QuantumStream' with a new 'Image Insights' overlay, integration of optional EndoNaut Aorta Iliac workflow, PCCplus position control, optional OR table controls, and a new 'Adult HQ' body size mode for 3D imaging with improved 3D visualization. The predicate and modified devices share substantially equivalent design controls, design, technology, and functionality.

Test standards cited

IEC 60601-1-2 (electromagnetic compatibility), 21 CFR 1020.30-32 (federal performance standards for X-ray fluoroscopic equipment), IEC 60601-1-3 (general requirements for safety), IEC 60601-2-43 (safety standards for X-ray equipment), IEC 60601-2-54, and FDA cybersecurity requirements for medical devices.

Substantial equivalence argument

The modified device employs identical fundamental control and substantially equivalent scientific technology as the predicate Ziehm Vision RFD 3D (K231701), with software enhancements that improve imaging chain performance and visualization capabilities. Image quality testing using anthropomorphic phantoms demonstrated that the modified device produces equal or superior image quality compared to the predicate system. Risk control assessments confirmed all device requirements were fulfilled, system functionality is consistent with user needs and intended uses, and verification/validation testing raised no new safety or effectiveness concerns.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →